Published in Cancer Res on June 13, 2013
Capillary transit time heterogeneity and flow-metabolism coupling after traumatic brain injury. J Cereb Blood Flow Metab (2014) 0.96
Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy. Int J Radiat Oncol Biol Phys (2015) 0.93
Reliable estimation of capillary transit time distributions using DSC-MRI. J Cereb Blood Flow Metab (2014) 0.89
PTEN deficiency and mutant p53 confer glucose-addiction to thyroid cancer cells: impact of glucose depletion on cell proliferation, cell survival, autophagy and cell migration. Genes Cancer (2014) 0.84
Serum lactate dehydrogenase and survival following cancer diagnosis. Br J Cancer (2015) 0.82
Cerebral small vessel disease: Capillary pathways to stroke and cognitive decline. J Cereb Blood Flow Metab (2015) 0.82
SHARP1 suppresses angiogenesis of endometrial cancer by decreasing hypoxia-inducible factor-1α level. PLoS One (2014) 0.82
Perfusion MRI derived indices of microvascular shunting and flow control correlate with tumor grade and outcome in patients with cerebral glioma. PLoS One (2015) 0.81
The effects of capillary dysfunction on oxygen and glucose extraction in diabetic neuropathy. Diabetologia (2014) 0.80
The role of capillary transit time heterogeneity in myocardial oxygenation and ischemic heart disease. Basic Res Cardiol (2014) 0.80
Microcirculatory dysfunction and tissue oxygenation in critical illness. Acta Anaesthesiol Scand (2015) 0.79
Biomarkers in preclinical cancer imaging. Eur J Nucl Med Mol Imaging (2015) 0.78
Acoustic resolution photoacoustic Doppler velocimetry in blood-mimicking fluids. Sci Rep (2016) 0.78
Delivery-corrected imaging of fluorescently-labeled glucose reveals distinct metabolic phenotypes in murine breast cancer. PLoS One (2014) 0.77
Could GLUT12 be a Potential Therapeutic Target in Cancer Treatment? A Preliminary Report. J Cancer (2015) 0.77
Loss of 11βHSD1 enhances glycolysis, facilitates intrahepatic metastasis, and indicates poor prognosis in hepatocellular carcinoma. Oncotarget (2016) 0.76
MicroRNA and extracellular vesicles in glioblastoma: small but powerful. Brain Tumor Pathol (2016) 0.76
Assessment of tumor oxygenation and its impact on treatment response in bevacizumab-treated recurrent glioblastoma. J Cereb Blood Flow Metab (2016) 0.75
Effect of Laryngeal Squamous Cell Carcinoma Tissue Implantation on the Chick Embryo Chorioallantoic Membrane: Morphometric Measurements and Vascularity. Biomed Res Int (2015) 0.75
Identification of a characteristic vascular belt zone in human colorectal cancer. PLoS One (2017) 0.75
The intragraft microenvironment as a central determinant of chronic rejection or local immunoregulation/tolerance. Curr Opin Organ Transplant (2016) 0.75
Human colorectal cancer cells induce vascular smooth muscle cell apoptosis in an exocrine manner. Oncotarget (2017) 0.75
Vascular-targeting therapies for treatment of malignant disease. Cancer (2004) 2.54
Plasma osteopontin, hypoxia, and response to the hypoxia sensitiser nimorazole in radiotherapy of head and neck cancer: results from the DAHANCA 5 randomised double-blind placebo-controlled trial. Lancet Oncol (2005) 2.10
The QUASAR reproducibility study, Part II: Results from a multi-center Arterial Spin Labeling test-retest study. Neuroimage (2009) 1.92
Differentiation and definition of vascular-targeted therapies. Clin Cancer Res (2005) 1.74
Is conscious perception gradual or dichotomous? A comparison of report methodologies during a visual task. Conscious Cogn (2006) 1.62
Changes in 3-dimensional bone structure indices in hypoparathyroid patients treated with PTH(1-84): a randomized controlled study. J Bone Miner Res (2012) 1.54
Vessel architectural imaging identifies cancer patient responders to anti-angiogenic therapy. Nat Med (2013) 1.46
[Concerning the Kurt Bjerregaard Stage's answer to our comment]. Ugeskr Laeger (2002) 1.40
Comparison of observed survival after ventricular assist device placement versus predicted survival without assist device using the Seattle heart failure model. ASAIO J (2012) 1.39
Size-Dependent Accumulation of PEGylated Silane-Coated Magnetic Iron Oxide Nanoparticles in Murine Tumors. ACS Nano (2009) 1.38
Comparison of 10 perfusion MRI parameters in 97 sub-6-hour stroke patients using voxel-based receiver operating characteristics analysis. Stroke (2009) 1.38
Aerobic glycolysis in cancers: implications for the usability of oxygen-responsive genes and fluorodeoxyglucose-PET as markers of tissue hypoxia. Int J Cancer (2008) 1.32
MRI detection of early blood-brain barrier disruption: parenchymal enhancement predicts focal hemorrhagic transformation after thrombolysis. Stroke (2008) 1.30
Matrix metalloproteinase-9 measured in urine from bladder cancer patients is an independent prognostic marker of poor survival. Acta Oncol (2010) 1.28
Seeing without Seeing? Degraded Conscious Vision in a Blindsight Patient. PLoS One (2008) 1.26
Remote ischemic perconditioning as an adjunct therapy to thrombolysis in patients with acute ischemic stroke: a randomized trial. Stroke (2013) 1.19
Current development status of small-molecule vascular disrupting agents. Curr Opin Investig Drugs (2006) 1.18
Quantitative t2 values predict time from symptom onset in acute stroke patients. Stroke (2009) 1.18
Experimentally and computationally fast method for estimation of a mean kurtosis. Magn Reson Med (2013) 1.18
The role of the microcirculation in delayed cerebral ischemia and chronic degenerative changes after subarachnoid hemorrhage. J Cereb Blood Flow Metab (2013) 1.18
T1- and T2*-dominant extravasation correction in DSC-MRI: part I--theoretical considerations and implications for assessment of tumor hemodynamic properties. J Cereb Blood Flow Metab (2011) 1.16
The role of the cerebral capillaries in acute ischemic stroke: the extended penumbra model. J Cereb Blood Flow Metab (2013) 1.12
Vascular targeted therapies in oncology. Cell Tissue Res (2008) 1.12
Cellular uptake of PET tracers of glucose metabolism and hypoxia and their linkage. Eur J Nucl Med Mol Imaging (2008) 1.07
Influence of oxygen concentration and pH on expression of hypoxia induced genes. Radiother Oncol (2005) 1.07
The capillary dysfunction hypothesis of Alzheimer's disease. Neurobiol Aging (2012) 1.04
Intravenous administration of Gd-DTPA prior to DWI does not affect the apparent diffusion constant. Magn Reson Imaging (2005) 1.03
Reduced prediagnostic 25-hydroxyvitamin D levels in women with breast cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev (2009) 1.01
Striatal dopamine release codes uncertainty in pathological gambling. Psychiatry Res (2012) 1.00
Effect of intratumoral heterogeneity in oxygenation status on FMISO PET, autoradiography, and electrode Po2 measurements in murine tumors. Int J Radiat Oncol Biol Phys (2005) 1.00
Assessment of hypoxia in experimental mice tumours by [18F]fluoromisonidazole PET and pO2 electrode measurements. Influence of tumour volume and carbogen breathing. Acta Oncol (2002) 0.96
Hypoxia induced expression of endogenous markers in vitro is highly influenced by pH. Radiother Oncol (2007) 0.95
Dopaminergic stimulation enhances confidence and accuracy in seeing rapidly presented words. J Vis (2011) 0.95
Prospective evaluation of angiogenic, hypoxic and EGFR-related biomarkers in recurrent glioblastoma multiforme treated with cetuximab, bevacizumab and irinotecan. APMIS (2010) 0.95
Can hypoxia-PET map hypoxic cell density heterogeneity accurately in an animal tumor model at a clinically obtainable image contrast? Radiother Oncol (2009) 0.94
Low cerebral oxygen consumption and blood flow in patients with cirrhosis and an acute episode of hepatic encephalopathy. Gastroenterology (2008) 0.94
Differential risk assessments from five hypoxia specific assays: The basis for biologically adapted individualized radiotherapy in advanced head and neck cancer patients. Radiother Oncol (2007) 0.94
Apparent Diffusion Coefficient (ADC) as a quantitative parameter in diffusion weighted MR imaging in gynecologic cancer: Dependence on b-values used. Acta Oncol (2010) 0.94
Resolution in PET hypoxia imaging: voxel size matters. Acta Oncol (2008) 0.94
Radiation administered as a large single dose or in a fractionated schedule: Role of the tumour vasculature as a target for influencing response. Acta Oncol (2006) 0.94
Radiosensitivity and effect of hypoxia in HPV positive head and neck cancer cells. Radiother Oncol (2013) 0.94
Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma. Eur J Nucl Med Mol Imaging (2004) 0.93
Carbogen inhalation increases oxygen transport to hypoperfused brain tissue in patients with occlusive carotid artery disease: increased oxygen transport to hypoperfused brain. Brain Res (2009) 0.93
Individual radiation response of parotid glands investigated by dynamic 11C-methionine PET. Radiother Oncol (2006) 0.92
Infarction of 'non-core-non-penumbral' tissue after stroke: multivariate modelling of clinical impact. Brain (2011) 0.91
Accessing the mental space-Spatial working memory processes for language and vision overlap in precuneus. Hum Brain Mapp (2008) 0.91
Imaging hypoxia in xenografted and murine tumors with 18F-fluoroazomycin arabinoside: a comparative study involving microPET, autoradiography, PO2-polarography, and fluorescence microscopy. Int J Radiat Oncol Biol Phys (2008) 0.90
The impact of hypoxia on the activity of lactate dehydrogenase in two different pre-clinical tumour models. Acta Oncol (2008) 0.90
Early effects of combretastatin-A4 disodium phosphate on tumor perfusion and interstitial fluid pressure. Neoplasia (2007) 0.90
Intravascular contrast agent-enhanced MRI measuring contrast clearance and tumor blood volume and the effects of vascular modifiers in an experimental tumor. Int J Radiat Oncol Biol Phys (2005) 0.89
Combretastatin A-4 phosphate affects tumor vessel volume and size distribution as assessed using MRI-based vessel size imaging. Clin Cancer Res (2012) 0.88
Proteins upregulated by mild and severe hypoxia in squamous cell carcinomas in vitro identified by proteomics. Radiother Oncol (2009) 0.88
Targeting the tumor vasculature: a strategy to improve radiation therapy. Expert Rev Anticancer Ther (2004) 0.88
Elevated T2-values in MRI of stroke patients shortly after symptom onset do not predict irreversible tissue infarction. Brain (2012) 0.87
Acute effects of vascular modifying agents in solid tumors assessed by noninvasive laser Doppler flowmetry and near infrared spectroscopy. Neoplasia (2002) 0.86
Accumulation of magnetic iron oxide nanoparticles coated with variably sized polyethylene glycol in murine tumors. Nanoscale (2012) 0.86
Predicting infarction within the diffusion-weighted imaging lesion: does the mean transit time have added value? Stroke (2011) 0.86
Non-invasive imaging of combretastatin activity in two tumor models: Association with invasive estimates. Acta Oncol (2010) 0.85
Cancer stem cell overexpression of nicotinamide N-methyltransferase enhances cellular radiation resistance. Radiother Oncol (2011) 0.85
Identifying pH independent hypoxia induced genes in human squamous cell carcinomas in vitro. Acta Oncol (2010) 0.85
Multiparametric analysis of magnetic resonance images for glioma grading and patient survival time prediction. Acta Radiol (2011) 0.85
Tapping polyrhythms in music activates language areas. Neurosci Lett (2011) 0.85
T(1)- and T(2)(*)-dominant extravasation correction in DSC-MRI: part II-predicting patient outcome after a single dose of cediranib in recurrent glioblastoma patients. J Cereb Blood Flow Metab (2011) 0.85
Accessing radiation response using hypoxia PET imaging and oxygen sensitive electrodes: a preclinical study. Radiother Oncol (2011) 0.85
Is conscious stimulus identification dependent on knowledge of the perceptual modality? Testing the "source misidentification hypothesis". Front Psychol (2013) 0.84
Predicting tissue outcome from acute stroke magnetic resonance imaging: improving model performance by optimal sampling of training data. Stroke (2009) 0.84
Biodistribution of 99mTc-HYNIC-lactadherin in mice--a potential tracer for visualizing apoptosis in vivo. Scand J Clin Lab Invest (2010) 0.84
Psychological aspects of endometriosis: differences between patients with or without pain on four psychological variables. Eur J Obstet Gynecol Reprod Biol (2007) 0.84
Initial evaluation of the antitumour activity of KGP94, a functionalized benzophenone thiosemicarbazone inhibitor of cathepsin L. Eur J Med Chem (2012) 0.83
Evaluation of endothelial cell culture as a model system of vascular ageing. Exp Gerontol (2010) 0.83
Preclinical studies to predict efficacy of vascular changes induced by combretastatin a-4 disodium phosphate in patients. Int J Radiat Oncol Biol Phys (2007) 0.82
Evaluation of anti-vascular therapy with texture analysis. Anticancer Res (2005) 0.82
The effect of combretastatin A4 disodium phosphate and 5,6-dimethylxanthenone-4-acetic acid on water diffusion and blood perfusion in tumours. Acta Oncol (2008) 0.81
Capillary dysfunction: its detection and causative role in dementias and stroke. Curr Neurol Neurosci Rep (2015) 0.81
The effects of the vascular disrupting agents combretastatin A-4 disodium phosphate, 5,6-dimethylxanthenone-4-acetic acid and ZD6126 in a murine tumour: a comparative assessment using MRI and MRS. Acta Oncol (2006) 0.81
Peritoneal macrophages mediated delivery of chitosan/siRNA nanoparticle to the lesion site in a murine radiation-induced fibrosis model. Acta Oncol (2012) 0.81
Treatment with the vascular disrupting agent combretastatin is associated with impaired AQP2 trafficking and increased urine output. Am J Physiol Regul Integr Comp Physiol (2012) 0.81
Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) in Preclinical Studies of Antivascular Treatments. Pharmaceutics (2012) 0.81
Interrater agreement for final infarct MRI lesion delineation. Stroke (2009) 0.81
Presymptomatic cerebral blood flow changes in CHMP2B mutation carriers of familial frontotemporal dementia (FTD-3), measured with MRI. BMJ Open (2012) 0.80
Segmentation of dynamic contrast enhanced magnetic resonance imaging data. Acta Oncol (2008) 0.80
Statistical mapping of effects of middle cerebral artery occlusion (MCAO) on blood flow and oxygen consumption in porcine brain. J Neurosci Methods (2006) 0.80
Impaired probability estimation and decision-making in pathological gambling poker players. J Gambl Stud (2012) 0.80
The role of capillary transit time heterogeneity in myocardial oxygenation and ischemic heart disease. Basic Res Cardiol (2014) 0.80
Induction of hypoxia by vascular disrupting agents and the significance for their combination with radiation therapy. Acta Oncol (2013) 0.80
Relationship between radiobiological hypoxia in a C3H mouse mammary carcinoma and osteopontin levels in mouse serum. Int J Radiat Biol (2005) 0.80
Making sense: Dopamine activates conscious self-monitoring through medial prefrontal cortex. Hum Brain Mapp (2015) 0.80
Accuracy of 18F-FDG PET-CT in triaging lung cancer patients with suspected brain metastases for MRI. Nucl Med Commun (2015) 0.80
Vascular effects of plinabulin (NPI-2358) and the influence on tumour response when given alone or combined with radiation. Int J Radiat Biol (2011) 0.80
Tracer kinetic model selection for dynamic contrast-enhanced magnetic resonance imaging of locally advanced cervical cancer. Acta Oncol (2014) 0.79
PET imaging of tumor hypoxia using 18F-labeled pimonidazole. Acta Oncol (2013) 0.79
In vivo identification and specificity assessment of mRNA markers of hypoxia in human and mouse tumors. BMC Cancer (2011) 0.79